-
Mashup Score: 7Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer - PubMed - 6 month(s) ago
Patients with active cancer were older (p < 0.001), more likely to be thrombocytopenic (p = 0.026), have moderate renal dysfunction (p = 0.005) and were more likely to receive lower-dose DOAC therapy (p < 0.001). A greater proportion of patients with active cancer underwent a high-bleed-risk p …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Workplace Pledge to Fight Antisemitism - 7 month(s) ago
Shine A Light is a national coalition initiative, spearheaded by several organizations including ADL, that raises awareness of antisemitism and promotes education and allyship during the holiday of Hanukkah (December 7-15, 2023). ADL has supported corporate engagement in Shine A Light for three years. The Workplace Pledge is ADL’s response to the White House’s landmark 2023 U.S. National…
Source: ADLCategories: Hem/Oncs, Latest HeadlinesTweet-
This should be easy to support. I hope you do: https://t.co/n0a061BFUS
-
-
Mashup Score: 3Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis - PubMed - 9 month(s) ago
The term heparin resistance (HR) is used by clinicians without specific criteria. We performed a literature search and surveyed our SSC membership to better define the term when applied to medical and ICU patients. The most common heparin dosing strategy reported in the literature 53%) and by survey …
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Heparin resistance remains a poorly defined phenomenon but #Covid_19 taught us its importance Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thromb… https://t.co/CZn5fWHuuh
-
-
Mashup Score: 0Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis - 11 month(s) ago
The effect of extended thromboprophylaxis in improving the prognosis of adult patients with coronavirus disease 2019 (COVID-19) after discharge remain…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
First meta-analysis showing benefits of extended TP in high-risk #Covid_19 flaws of ACTIVE-IVc well established @NATFthrombosis @PERTConsortium @AnticoagForum @canvector @EuropeanTHA @escardio @ThrombosisUK @TromboseLeiden @ThrombosisCan @CardiologyToday https://t.co/AMaJbHbRp3
-
-
Mashup Score: 1
In patients at high risk of thromboembolism who were discharged after hospitalisation due to COVID-19, thromboprophylaxis with rivaroxaban 10 mg/day f…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Extended TP is cost-effective in high risk #COVID19 patients @NATFthrombosis @PERTConsortium @canvector @thrombosisday @ThrombosisUK @ThrombosisCan @escardio @EuropeanTHA @TromboseLeiden @AnticoagForum @CardiologyToday https://t.co/lQqkPFWmZw
-
-
Mashup Score: 0Journal of Clinical Medicine Receives an Increased CiteScore of 5.4 - 11 month(s) ago
We are pleased to inform you that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has received an updated CiteScore…
Source: www.mdpi.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Journal of Clinical Medicine Receives an Increased CiteScore of 5.4 https://t.co/bhYW0D1L9D # via @MDPIOpenAccess
-
-
Mashup Score: 0Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial - PubMed - 1 year(s) ago
gov; Unique identifier: NCT04508023.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Largest outpatient thrombopropohylaxis trial of #Covid_19 shows low #thrombosis rates and no advantage with DOAC https://t.co/CwhC6nJRv6 @NATFthrombosis @PERTConsortium @ThrombosisUK @ThrombosisCan @EuropeanTHA @canvector @AnticoagForum @escardio @CardiologyToday @TromboseLeiden
-
-
Mashup Score: 0
Background Coronavirus disease 2019 (COVID-19) is associated with venous and arterial thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients. High-quality data are needed on post-discharge outcomes in patients with cardiovascular disease. Objectives To analyze outcomes …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
High rates of #ATE #VTE and mortality post-discharge in #COVID19 inpatients with cardiovascular comorbidities @PERTConsortium @NATFthrombosis @ThrombosisCan @ThrombosisUK @canvector @escardio @EuropeanTHA @TH_Journal @thrombosisday @AnticoagForum @isth https://t.co/iqtZdzm9Dm
-
-
Mashup Score: 1Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma - 1 year(s) ago
This randomized clinical trial examines whether systematic 4-factor prothrombin complex concentrate administration combined with a ratio-based transfusion protocol is superior to ratio-based transfusion alone in reducing 24-hour total blood product consumption in patients at risk of massive…
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
No efficacy and more #thrombosis with 4F-PCC in trauma https://t.co/ZPs8xWmhQz @AnticoagForum @NATFthrombosis @canvector @ThrombosisCan @ThrombosisUK @EuropeanTHA @PERTConsortium @escardio @TromboseLeiden @isth @CardiologyToday @MedscapeCME #ZuckerSOm
-
-
Mashup Score: 0VENOUSEDGE.COM - 1 year(s) ago
An online review of all things venous. Venous Edge with venous experts providing an online venous magazine.
Source: VENOUSEDGE.COMCategories: Hem/Oncs, Latest HeadlinesTweet-
Nice podcast on 2022 Perioperative Chest Antithrombotic Guidelines for #thrombosis #perioperative @NATFthrombosis @canvector @ThrombosisCan @ThrombosisUK @escardio @PERTConsortium @EuropeanTHA @isth @AnticoagForum @TromboseLeiden https://t.co/d8U3QYlzC1
-
Active #Cancer independent risk factor for major bleeding in elective #surgery Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer. https://t.co/FjStgrnD8c @NATFthrombosis @PERTConsortium @canvector @AnticoagForum